Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

368

HTML

4344

Tables (1-2)

159

Sum=4871

Feb 14, 2012 (publication date) through Jun 21, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Feb 14, 2012; 18(6): 498-506
Published online Feb 14, 2012. doi: 10.3748/wjg.v18.i6.498

Table 2 Agents with antiangiogenic properties in development for the treatment of hepatocellular carcinoma

Citation: Frenette C, Gish R. Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications. World J Gastroenterol 2012; 18(6): 498-506
URL: https://www.wjgnet.com/1007-9327/full/v18/i6/498.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i6.498